| Dr Brian Michael Capogna, MD | |
|
805 Saint Vincents Dr Ste 100, Birmingham, AL 35205-1638 | |
| (205) 939-3699 | |
| (205) 581-7155 |
| Full Name | Dr Brian Michael Capogna |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 12 Years |
| Location | 805 Saint Vincents Dr Ste 100, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316207053 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD.35957 (Alabama) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Catholic Home Care | Farmingdale, NY | Home health agency |
| St Francis Hospital - The Heart Center | Roslyn, NY | Hospital |
| North Shore University Hospital | Manhasset, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedic And Neurosurgery Specialists, Pllc | 5294628947 | 208 |
News Archive
HIV, the virus that causes AIDS, has become one of the world's most serious health and development challenges.
A new British review of existing research suggests that while a newer type of radiation for the treatment of prostate cancer does not help patients live longer compared to an older type at least when similar doses are given it does appear to reduce gastrointestinal side effects.
Sosei Group Corporation, today announces that NVA237 (glycopyrronium bromide), a long-acting muscarinic antagonist (LAMA) being investigated as a once-daily treatment for chronic obstructive pulmonary disease (COPD), has been filed by Novartis for marketing authorisation with the European Medicines Agency (EMA), under the brand-name Seebri Breezhaler, triggering a $5m milestone payment to Sosei.
With obesity reaching epidemic levels, researchers at the Ohio State University Medical Center are studying a potentially long-term treatment that involves injecting a gene directly into one of the critical feeding and weight control centers of the brain.
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced financial and operational results for the second quarter and six months ended June 30, 2010.
› Verified 7 days ago
| Entity Name | Orthopaedic Associates Of Manhasset Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922092717 PECOS PAC ID: 0446213680 Enrollment ID: O20041108001262 |
News Archive
HIV, the virus that causes AIDS, has become one of the world's most serious health and development challenges.
A new British review of existing research suggests that while a newer type of radiation for the treatment of prostate cancer does not help patients live longer compared to an older type at least when similar doses are given it does appear to reduce gastrointestinal side effects.
Sosei Group Corporation, today announces that NVA237 (glycopyrronium bromide), a long-acting muscarinic antagonist (LAMA) being investigated as a once-daily treatment for chronic obstructive pulmonary disease (COPD), has been filed by Novartis for marketing authorisation with the European Medicines Agency (EMA), under the brand-name Seebri Breezhaler, triggering a $5m milestone payment to Sosei.
With obesity reaching epidemic levels, researchers at the Ohio State University Medical Center are studying a potentially long-term treatment that involves injecting a gene directly into one of the critical feeding and weight control centers of the brain.
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced financial and operational results for the second quarter and six months ended June 30, 2010.
› Verified 7 days ago
| Entity Name | Orthopaedic & Neurosurgery Specialists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033318720 PECOS PAC ID: 5294628947 Enrollment ID: O20170828001424 |
News Archive
HIV, the virus that causes AIDS, has become one of the world's most serious health and development challenges.
A new British review of existing research suggests that while a newer type of radiation for the treatment of prostate cancer does not help patients live longer compared to an older type at least when similar doses are given it does appear to reduce gastrointestinal side effects.
Sosei Group Corporation, today announces that NVA237 (glycopyrronium bromide), a long-acting muscarinic antagonist (LAMA) being investigated as a once-daily treatment for chronic obstructive pulmonary disease (COPD), has been filed by Novartis for marketing authorisation with the European Medicines Agency (EMA), under the brand-name Seebri Breezhaler, triggering a $5m milestone payment to Sosei.
With obesity reaching epidemic levels, researchers at the Ohio State University Medical Center are studying a potentially long-term treatment that involves injecting a gene directly into one of the critical feeding and weight control centers of the brain.
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced financial and operational results for the second quarter and six months ended June 30, 2010.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Michael Capogna, MD 300 E 23rd St Apt 11b, New York, NY 10010-4782 Ph: (516) 647-5941 | Dr Brian Michael Capogna, MD 805 Saint Vincents Dr Ste 100, Birmingham, AL 35205-1638 Ph: (205) 939-3699 |
News Archive
HIV, the virus that causes AIDS, has become one of the world's most serious health and development challenges.
A new British review of existing research suggests that while a newer type of radiation for the treatment of prostate cancer does not help patients live longer compared to an older type at least when similar doses are given it does appear to reduce gastrointestinal side effects.
Sosei Group Corporation, today announces that NVA237 (glycopyrronium bromide), a long-acting muscarinic antagonist (LAMA) being investigated as a once-daily treatment for chronic obstructive pulmonary disease (COPD), has been filed by Novartis for marketing authorisation with the European Medicines Agency (EMA), under the brand-name Seebri Breezhaler, triggering a $5m milestone payment to Sosei.
With obesity reaching epidemic levels, researchers at the Ohio State University Medical Center are studying a potentially long-term treatment that involves injecting a gene directly into one of the critical feeding and weight control centers of the brain.
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced financial and operational results for the second quarter and six months ended June 30, 2010.
› Verified 7 days ago
James Russell Bowman, M.D./ PHD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2700 10th Ave S Ste 200, Birmingham, AL 35205 Phone: 205-933-7838 | |
Jan Kenjiro Vonhoegen, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 720 Montclair Rd, Birmingham, AL 35213 Phone: 205-397-5200 Fax: 205-397-5220 | |
Victoria Masear, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 48 Medical Park E Dr, Suite 200, Birmingham, AL 35235 Phone: 205-838-3090 Fax: 205-838-6783 | |
Abhinav Agarwal, M.B.B.S. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S Fl 3, Birmingham, AL 35233 Phone: 205-801-8630 Fax: 205-975-9532 | |
Stephen Patrick Cowley, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 720 Montclair Rd, Suite101, Birmingham, AL 35213 Phone: 205-397-5200 Fax: 205-397-5210 | |
Chong Weng, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 510 20th St S, Birmingham, AL 35233 Phone: 205-930-8339 | |
Patrick Reid Peavy, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1801 Gadsden Hwy, Birmingham, AL 35235 Phone: 205-838-3900 Fax: 205-838-3906 |